3.4. Cost-effectiveness analysis
The treatment cost of group A was about 305.54, the treatment cost of group B vonoprazan for a period of B was about 226.39, the treatment cost of group C was about 447.32, the cost effect ratio of group A was 3.30 (305.54/92.5), the cost effect ratio of group B was 2.47 (226.39/91.6), and the cost effect ratio of group C was 5.58 (447.32/ 80.1). Collectively, group A has the lowest cost-effect ratio and is better than groups B and C.